A simple yet multifaceted 90 years old, evergreen enzyme: Carbonic anhydrase, its inhibition and activation

CT Supuran - Bioorganic & Medicinal Chemistry Letters, 2023 - Elsevier
Advances in the carbonic anhydrase (CA, EC 4.2. 1.1) research over the last three decades
are presented, with an emphasis on the deciphering of the activation mechanism, the …

Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?

V Alterio, A Di Fiore, K D'Ambrosio, CT Supuran… - Chemical …, 2012 - ACS Publications
Carbonic anhydrases (CAs, EC 4.2. 1.1) are ubiquitous metallo-enzymes, present
throughout most living organisms and encoded by five evolutionarily unrelated gene …

Carbonic anhydrases: novel therapeutic applications for inhibitors and activators

CT Supuran - Nature reviews Drug discovery, 2008 - nature.com
Carbonic anhydrases (CAs), a group of ubiquitously expressed metalloenzymes, are
involved in numerous physiological and pathological processes, including …

Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein− ligand binding

VM Krishnamurthy, GK Kaufman, AR Urbach… - Chemical …, 2008 - ACS Publications
Carbonic anhydrase (CA, EC 4.2. 1.1) is a protein that is especially well-suited to serve as a
model in many types of studies in biophysics, bioanalysis, the physical-organic chemistry of …

[图书][B] Carbonic anhydrase: its inhibitors and activators

CT Supuran, A Scozzafava, J Conway - 2004 - books.google.com
Carbonic Anhydrase: Its Inhibitors and Activators provides a state-of-the-art overview of the
latest developments and challenges in carbonic anhydrase research. Authors describe the …

Carbonic anhydrases as potential targets against neurovascular unit dysfunction in Alzheimer's disease and stroke

N Lemon, E Canepa, MA Ilies, S Fossati - Frontiers in aging …, 2021 - frontiersin.org
The Neurovascular Unit (NVU) is an important multicellular structure of the central nervous
system (CNS), which participates in the regulation of cerebral blood flow (CBF), delivery of …

Carbonic anhydrase activators

CT Supuran - Future medicinal chemistry, 2018 - Taylor & Francis
Mammalian carbonic anhydrases (CAs; EC 4.2. 1.1) of which 16 isoforms are known, are
involved in important physiological functions. Their inhibition is exploited pharmacologically …

Applications of carbonic anhydrase inhibitors and activators in therapy

CT Supuran, A Scozzafava - Expert Opinion on Therapeutic Patents, 2002 - Taylor & Francis
Inhibitors and activators of the zinc enzyme carbonic anhydrase (CA, EC 4.2. 1.1) have a
large number of applications in therapy. Many types of such new derivatives have been …

Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule

F Carta, C Temperini, A Innocenti… - Journal of Medicinal …, 2010 - ACS Publications
Carbonic anhydrases (CAs, EC 4.2. 1.1) are inhibited by sulfonamides, phenols, and
coumarins. Polyamines such as spermine, spermidine, and many synthetic congeners are …

Synthesis, molecular modeling, and biological evaluation of 4‐[5‐aryl‐3‐(thiophen‐2‐yl)‐4,5‐dihydro‐1H‐pyrazol‐1‐yl] benzenesulfonamides toward …

C Yamali, HI Gul, A Ece, P Taslimi… - Chemical biology & drug …, 2018 - Wiley Online Library
In this study, 4‐[5‐aryl‐3‐(thiophen‐2‐yl)‐4, 5‐dihydro‐1H‐pyrazol‐1‐yl]
benzenesulfonamides were synthesized, and inhibition effects on AC hE, hCA I, and hCA II …